AcuityMD Raises $80M to Expand AI MedTech Platform

AcuityMD announced an $80 million Series C financing at a $955 million valuation, led by StepStone Group with participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. The raise brings total capital to over $160 million and funds immediate investment in agentic AI, a deeper MedTech ontology, and expansion of the platform beyond commercial functions.

AcuityMD operates a data-first intelligence stack that fuses a proprietary MedTech ontology with multiple enterprise and public data sources to produce actionable recommendations for commercial teams. The company is rolling out AcuityAI, an agentic, role-aware layer in open beta that answers complex commercial questions and generates executable plans for territory prioritization, account targeting, and launch sequencing. Key platform components include:

• •Aggregated external data sets such as claims databases, FDA filings, and government records that provide market signals and reimbursement context.
• •A continuously enriched knowledge graph and MedTech ontology that maps physicians, facilities, networks, procedures, and reimbursement dynamics to products and contracts.
• •Integration with internal customer systems, including CRM and contracting data, to align external signals with company-specific territory structures and product indications.

The product emphasizes role-specific outputs: field reps get rapid, actionable intel at point of engagement, while commercial leaders receive prioritization plans and pipeline forecasts. AcuityMD cites adoption metrics including support for over 400 MedTech organizations, usage by 16 of the top 20 global firms, and identification of more than $34 billion in potential pipeline to date.

This round is a clear indicator that investors value verticalized, domain-rich AI stacks in healthcare. MedTech commercial operations face fast-moving headwinds from hospital consolidation, shifting reimbursement, and tighter procurement cycles, which increases demand for systems that convert fragmented healthcare data into contextual recommendations. AcuityMD's strategy builds a data moat around a specialized ontology and analytics layer, positioning it as infrastructure rather than a point tool. The move toward agentic workflows mirrors a broader industry trend: domain-specific AI agents that combine knowledge graphs and LLM-style reasoning to produce executable, auditable plans rather than standalone answers.

For practitioners, the company highlights several practical implications. First, model utility scales with curated, longitudinal domain data; generalized LLMs alone are insufficient for nuanced commercial decisioning. Second, AcuityAI illustrates how agentic features are being embedded into enterprise workflows, increasing expectations for role-based prompts, contextual grounding, and CRM integration. Third, the expansion beyond commercial into lifecycle functions signals opportunities for AI to support R&D prioritization, regulatory strategy, and launch operations when underpinned by the same ontology.

Monitor how AcuityMD governs data lineage, model explainability, and privacy when surfacing recommendations tied to prescribing and contracting behavior. Also watch customer retention and the company's ability to translate agentic outputs into measurable lift in sales KPIs, and whether competitors or large incumbents replicate the ontology-driven approach.